HIV infects subset of T cells leading to depletion, Gladstone researchers find

October 16, 2001

The battalion of CD4+ T cells, which fight HIV and other pathogens, needs new recruits to replace the cells that fall. Researchers at the Gladstone Institute of Virology and Immunology and co-authors have found that these recruits, called naïve T cells, are susceptible to the bullets of HIV infection even before they step onto the battlefield.

The study, published in the October 17 issue of the journal Immunity, is among the first to show that HIV can indeed infect naïve T cells and brings some resolution to what was the subject of great debate among HIV researchers. The finding helps to explain how T-cell numbers diminish to levels that leave the body susceptible to opportunistic infections characteristic of AIDS.

"The collapse of the CD4+ T-cell system is the cardinal feature of AIDS, so understanding which subsets of T cells can be infected is important in providing a clear picture of how HIV reduces the number of T cells," said senior co-author Mark A. Goldsmith, MD, PhD, associate investigator at Gladstone and UCSF associate professor of medicine.

CD4+ T cells are divided into two basic classes--naïve cells and memory cells. Once exposed to a pathogen, naïve cells become memory cells, which signal other immune system cells to mount an attack on the offending pathogen. Conventional wisdom was that HIV infected memory T cells nearly exclusively.

Such thinking resulted from studies that used T cells isolated from blood, Goldsmith said. But only 2 percent of all immune system cells are circulating in the blood at once, so these cells may not be sufficiently representative. Also, culturing these cells requires the use of artificial stimulants, changing the way they react to the environment.

Goldsmith and lead author Daniel A. Eckstein, a UCSF Biomedical Sciences Program graduate student at Gladstone, instead focused on the cells found in lymphoid organs, such as the spleen, lymph nodes, and tonsils, where most immune system cells are located. Because cells in these tissues can be cultured without artificial stimulants, their behavior closely mirrors that found in the body.

Before this study, other researchers had claimed to have isolated HIV-infected naïve cells from infected individuals. Some HIV researchers, however, suspected that these cells were merely infected memory cells that had reverted back to a naïve character. The current study clears away those suspicions and shows that naïve cells themselves can indeed be infected.

In one experiment, the researchers infected naïve cells with HIV. In addition, they added BrdU, a substance that shows up in cells that have divided. Generally, naïve cells don't divide. Memory cells do. About 14 percent of the naïve cells were infected, while only 2 percent were labeled with BrdU. This shows that the vast majority of the cells that were infected had not divided. The infected cells were naïve cells and not dividing memory cells.

The discovery could change the way physicians think of the way HIV infection leads to AIDS. Infected naïve cells are a source of HIV, helping it to spread throughout the body. These infected naïve cells also die and then are no longer available to replenish the immune system.

Without these CD4+ T cells, the virus "eliminates the ability of the immune system to respond to the opportunistic infections characteristic of AIDS," said Eckstein, who is also a medical student in UCSF School of Medicine's Medical Scientist Training Program.

The specific HIV strain that the researchers employed is classified as an "X4" virus; such strains are found in 50 percent to 90 percent of patients during the later stages of infection. Eckstein said that the study underscores the importance of developing a drug to antagonize a specific protein involved in X4 HIV infection.
Gladstone researchers also involved in the study include Michael L. Penn, PhD, former graduate student in the UCSF Biomedical Sciences Program and medical student in the Medical Scientist Training Program in the UCSF School of Medicine; Jason F. Kreisberg, BS, graduate student in the UCSF Biomedical Sciences Program; research scientist Michael P. Sherman, MD, PhD, UCSF assistant clinical professor of medicine; and research associate Peggy S. Chin, BA.

Co-authors from the UCLA department of microbiology, immunology and molecular genetics include graduate student Dierdre D. Scripture-Adams, BS, and Jerome A. Zack, PhD, professor of hematology and oncology in the UCLA department of medicine. Also co-authors were Yael D. Korin, PhD, UCLA postdoctoral fellow in the department of medicine, and Mario Roederer, PhD, chief of the immunotechnology section of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

The work was supported by grants from the National Institutes of Health, the UCSF Biomedical Sciences Graduate Program, the Medical Scientist Training Program at UCSF, the California Universitywide AIDS Research Program, the National Science Foundation, the UCSF-California AIDS Research Center, and the J. David Gladstone Institutes.

The Gladstone Institute of Virology and Immunology is one of three research institutes that comprise the J. David Gladstone Institutes, a private biomedical research institution affiliated with the University of California, San Francisco. The institutes are named for a prominent real estate developer who died in 1971. His will created a testamentary trust that reflects his long-standing personal interest in medical education and research.

University of California - San Francisco

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to